Michael Innocenzo - 02 Feb 2026 Form 4 Insider Report for EXELON CORP (EXC)

Role
EVP & Chief Operating Officer
Signature
David T Skinner, attorney-in-fact for Michael Innocenzo
Issuer symbol
EXC
Transactions as of
02 Feb 2026
Net transactions value
-$735,317
Form type
4
Filing time
04 Feb 2026, 16:25:07 UTC
Previous filing
04 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Innocenzo Michael EVP & Chief Operating Officer 10 S DEARBORN STREET, 54TH FLOOR, CHICAGO David T Skinner, attorney-in-fact for Michael Innocenzo 04 Feb 2026 0001735897

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise +2,432 +3.2% 78,511 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +5,748 +7.3% 84,259 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +7,734 +9.2% 91,993 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +11,555 +13% 103,548 02 Feb 2026 Direct F2
transaction EXC Common Stock Tax liability $419,209 -9,547 -9.2% $43.91 94,001 02 Feb 2026 Direct
transaction EXC Common Stock Disposed to Issuer $316,108 -7,199 -7.7% $43.91 86,802 02 Feb 2026 Direct
holding EXC Common Stock ESPP 2,835 02 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2023 Restricted Stock Units Options Exercise -2,432 -100% 0 02 Feb 2026 Common Stock 2,432 Direct F1, F3
transaction EXC 2024 Restricted Stock Units Options Exercise -5,748 -50% 5,746 02 Feb 2026 Common Stock 5,748 Direct F1, F4
transaction EXC 2025 Restricted Stock Units Options Exercise -7,734 -33% 15,466 02 Feb 2026 Common Stock 7,734 Direct F1, F5
transaction EXC 2026 Restricted Stock Units Award $0 +20,668 $0.000000 20,668 02 Feb 2026 Common Stock 20,668 Direct F1
transaction EXC 2023-2025 Performance Shares Award $0 +11,555 $0.000000 11,555 02 Feb 2026 Common Stock 11,555 Direct F2
transaction EXC 2023-2025 Performance Shares Options Exercise -11,555 -100% 0 02 Feb 2026 Common Stock 11,555 Direct F2
holding EXC Deferred phantom share equivalents 2,274 02 Feb 2026 Common Stock 2,274 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit (RSU) award granted under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment, and the additional RSUs vest on the same schedule as the underlying award.
F2 Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
F3 Balance at the time of this vesting includes 87 additional shares acquired through automatic dividend reinvestment during 2025.
F4 Balance at the time of this vesting includes 412 additional shares acquired through automatic dividend reinvestment during 2025.
F5 Balance at the time of this vesting includes 831 additional shares acquired through automatic dividend reinvestment during 2025.
F6 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
F7 Balance as of 12/31/2025 and includes 79 phantom share equivalents accrued during 2025 through automatic dividend reinvestment.